Mixed States in Bipolar Disorder: Etiology, Pathogenesis and Treatment
- Author:
Ather MUNEER
1
Author Information
- Publication Type:Review
- Keywords: Bipolar Disorder; Depressive Disorder, Major; Acetylcholine; Catecholamines; Dopamine
- MeSH: Acetylcholine; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Catecholamines; Depressive Disorder, Major; Dopamine; Electroconvulsive Therapy; Genetic Predisposition to Disease; Humans; Mood Disorders; Prognosis; Synaptic Transmission
- From:Chonnam Medical Journal 2017;53(1):1-13
- CountryRepublic of Korea
- Language:English
- Abstract: Many bipolar disorder patients exhibit mixed affective states, which portend a generally more severe illness course and treatment resistance. In the previous renditions of Diagnostic and Statistical Manual mixed states were narrowly defined in the context of bipolar I disorder, but with the advent of DSM-5 the term “mixed episode” was dropped and replaced by “mixed features” specifier which could be broadly applied to manic, hypomanic and depressive episodes in both the bipolar spectrum and major depressive disorders. This paradigm shift reflected their significance in the prognosis and overall management of mood disorders, so that the clinicians should thoroughly familiarize themselves with the contemporary notions surrounding these conditions. The purpose of this manuscript is to bring to light the current conceptualizations regarding the etiology, pathogenesis and treatment of mixed states. To achieve this goal, in June 2016 an extensive literature search was undertaken using the PubMed database. Some exploratory terms utilized included “mixed states”, “mixed episodes”, “switching”, “rapid cycling” cross referenced with “bipolar disorder”. Focusing on the most relevant and up to date studies, it was revealed that mixed states result from genetic susceptibility in the circadian and dopamine neurotransmission apparatuses and disturbance in the intricate catecholamine-acetylcholine neurotransmission balance which leads to mood fluctuations. The management of mixed states is challenging with atypical antipsychotics, newer anticonvulsants and electroconvulsive therapy emerging as the foremost treatment options. In conclusion, while progress has been made in the neurobiological understanding of mixed states, the currently available therapeutic modalities have only shown limited effectiveness.
